Literature DB >> 11416140

Downregulation of CIITA function by protein kinase a (PKA)-mediated phosphorylation: mechanism of prostaglandin E, cyclic AMP, and PKA inhibition of class II major histocompatibility complex expression in monocytic lines.

G Li1, J A Harton, X Zhu, J P Ting.   

Abstract

Prostaglandins, pleiotropic immune modulators that induce protein kinase A (PKA), inhibit gamma interferon induction of class II major histocompatibility complex (MHC) genes. We show that phosphorylation of CIITA by PKA accounts for this inhibition. Treatment with prostaglandin E or 8-bromo-cyclic AMP or transfection with PKA inhibits the activity of CIITA in both mouse and human monocytic cell lines. This inhibition is independent of other transcription factors for the class II MHC promoter. These same treatments also greatly reduced the induction of class II MHC mRNA by CIITA. PKA phosphorylation sites were identified using site-directed mutagenesis and phosphoamino acid analysis. Phosphorylation at CIITA serines 834 and 1050 accounts for the inhibitory effects of PKA on CIITA-driven class II MHC transcription. This is the first demonstration that the posttranslational modification of CIITA mediates inhibition of class II MHC transcription.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416140      PMCID: PMC87128          DOI: 10.1128/MCB.21.14.4626-4635.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  HIV-1 Tat mutants in the cysteine-rich region downregulate HLA class II expression in T lymphocytic and macrophage cell lines.

Authors:  G Tosi; A De Lerma Barbaro; A D'Agostino; M T Valle; A M Megiovanni; F Manca; A Caputo; G Barbanti-Brodano; R S Accolla
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

2.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.

Authors:  K Masternak; A Muhlethaler-Mottet; J Villard; M Zufferey; V Steimle; W Reith
Journal:  Genes Dev       Date:  2000-05-01       Impact factor: 11.361

Review 3.  Association of STATs with relatives and friends.

Authors:  M Chatterjee-Kishore; F van den Akker; G R Stark
Journal:  Trends Cell Biol       Date:  2000-03       Impact factor: 20.808

Review 4.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Associations and interactions between bare lymphocyte syndrome factors.

Authors:  A M DeSandro; U M Nagarajan; J M Boss
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  Introduction of exogenous class II trans-activator in MHC class II-deficient ABI fibroblasts results in incomplete rescue of MHC class II antigen expression.

Authors:  A Peijnenburg; S J Gobin; M C van Eggermond; B C Godthelp; N van Graafeiland; P J van den Elsen
Journal:  J Immunol       Date:  1997-09-15       Impact factor: 5.422

7.  Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.

Authors:  A Peijnenburg; R Van den Berg; M J Van Eggermond; O Sanal; J M Vossen; A M Lennon; C Alcaïde-Loridan; P J Van den Elsen
Journal:  Immunogenetics       Date:  2000-01       Impact factor: 2.846

8.  Hyperphosphorylation and increased proteolytic breakdown of c-Myb induced by the inhibition of Ser/Thr protein phosphatases.

Authors:  J Bies; S Feiková; D P Bottaro; L Wolff
Journal:  Oncogene       Date:  2000-06-01       Impact factor: 9.867

9.  Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.

Authors:  X S Zhu; M W Linhoff; G Li; K C Chin; S N Maity; J P Ting
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

10.  MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300.

Authors:  T J Sisk; T Gourley; S Roys; C H Chang
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

View more
  21 in total

1.  Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.

Authors:  Kavita Purnanda Bhat; Agnieszka Dorota Truax; Susanna Fletcher Greer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Optimal transactivation by Epstein-Barr nuclear antigen 1 requires the UR1 and ATH1 domains.

Authors:  Gyanendra Singh; Siddhesh Aras; Arnold H Zea; Shahriar Koochekpour; Ashok Aiyar
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

3.  The Kidney Contains Ontogenetically Distinct Dendritic Cell and Macrophage Subtypes throughout Development That Differ in Their Inflammatory Properties.

Authors:  Natallia Salei; Stephan Rambichler; Johanna Salvermoser; Nikos E Papaioannou; Ronja Schuchert; Dalia Pakalniškytė; Na Li; Julian A Marschner; Julia Lichtnekert; Christopher Stremmel; Filippo M Cernilogar; Melanie Salvermoser; Barbara Walzog; Tobias Straub; Gunnar Schotta; Hans-Joachim Anders; Christian Schulz; Barbara U Schraml
Journal:  J Am Soc Nephrol       Date:  2020-01-13       Impact factor: 10.121

4.  Molecular characterization of chicken class II transactivator gene.

Authors:  Gholamreza Nikbakht Brujeni; Mohammad Khosravi
Journal:  Immunogenetics       Date:  2014-10-24       Impact factor: 2.846

5.  Prostaglandin E₂ suppresses allergic sensitization and lung inflammation by targeting the E prostanoid 2 receptor on T cells.

Authors:  Zbigniew Zasłona; Katsuhide Okunishi; Emilie Bourdonnay; Racquel Domingo-Gonzalez; Bethany B Moore; Nicholas W Lukacs; David M Aronoff; Marc Peters-Golden
Journal:  J Allergy Clin Immunol       Date:  2013-09-24       Impact factor: 10.793

6.  Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters.

Authors:  Giovanna Tosi; Nabila Jabrane-Ferrat; B Matija Peterlin
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

7.  Major histocompatibility class II transactivator expression in smooth muscle cells from A2b adenosine receptor knock-out mice: cross-talk between the adenosine and interferon-gamma signaling.

Authors:  Yong Xu; Katya Ravid; Barbara D Smith
Journal:  J Biol Chem       Date:  2008-03-21       Impact factor: 5.157

8.  Patterned variation in murine MHC promoters.

Authors:  N Avrion Mitchison; Jurgen Roes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-19       Impact factor: 11.205

9.  Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages.

Authors:  Justin E Wilson; Bhuvana Katkere; James R Drake
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

10.  Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.

Authors:  Lilien N Voong; Allison R Slater; Sebila Kratovac; Drew E Cressman
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.